A laboratory approach to the evaluation of hereditary hypercoagulability.
The concept of hypercoagulability and especially its evaluation in the clinical laboratory has changed dramatically during the last few years. The genetic basis and the mechanisms of the various factors responsible for hypercoagulability are briefly reviewed with emphasis on the most common genetic deficiencies. The major thrust of this review centers on the cost-effective approach to examining patients with a personal or family history of venous thrombosis. Several new concepts dealing with thrombotic risk are presented with a focus on the theory that multiple factors cause thrombosis in affected patients. A proposal for a cost-effective sequential testing scheme for the accurate diagnosis of hereditary hypercoagulability is discussed. The knowledge of thrombotic risk factors is evolving rapidly, requiring the clinical laboratory to remain flexible. Ultimately, the clinical laboratory must take a leading role in the diagnosis of hereditary thrombotic disease by serving as the consultant to the primary caregiver by providing an up-to-date and cost-effective evaluation.
Adcock
D M
DM
Department of Pathology, Colorado Permanente Medical Group, Aurora, USA.
Fink
L
L
Marlar
R A
RA
D000990:Antithrombin III / Q000235:genetics / Q000502:physiology; D001780:Blood Coagulation Tests; D005165:Factor V / Q000235:genetics; D006710:Homocysteine / Q000097:blood; D006801:Humans; D011486:Protein C / Q000235:genetics / Q000502:physiology; D017293:Protein S / Q000235:genetics / Q000502:physiology; D012307:Risk Factors; D013924:Thrombophlebitis / Q000235:genetics*
D011486:Protein C; D017293:Protein S; C095381:factor V Leiden; D006710:Homocysteine; D000990:Antithrombin III; D005165:Factor V